Webvent

SCRS Sites Directory

Search SCRS member sites. Discover current trials.

MTZ Clinical Research Sp.

MTZ Clinical Research Sp. z o.o. (MTZ) is an inspected CRO with own Clinical Research Site; focused on early clinical research development and biosimilar in healthy

MTZ Clinical Research Sp.

Since 2002 European and American pharmaceutical companies and Contract Research Organizations (CROs) have availed themselves of the services of MTZ Clinical Research (MTZ) a leading Polish company specializing in early phase clinical trials, bioequivalence and bioavailability studies.

Most studies are conducted at Company’s clinical research site which accommodates up to 30 subjects. It is also used as a specialized site for Phase III studies. MTZ also conducts single and multicentre trials (Phase II) at specialized clinics across Poland. Since August 2009 Company holds ISO 9001:2008, and from 2018 ISO 9001:2015 Certificate from DAS CERTIFICATION Ltd. accredited by UKAS.
MTZ conducts the following type of studies:
- Phase I/II healthy & patients, various indications
- Biosimilars healthy & patients
- Special populations
- Proof-of-Concept
- Bioequivalence and Bioavailability
- PK/PD, Food effect studies
- Therapeutic equivalence
- Tobacco risk evaluation & smoking-cessation studies.

MTZ has conducted over 260 research projects with over 6200 participating healthy subjects and patients who are recruited mainly from Company’s own registered database of volunteers.

Web Site: mtz-clinical.com 

Information

Demographic Data

  • SITE INFORMATION 
  • Start year clinical research2002
  • Phases of clinical studiesPhase I, Phase II, Phase III
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals
  • PopulationsAdult 18-64 yrs, Senior 65 yrs and over
  • SPECIFIC SITE INFORMATION 
  • Type of siteFreestanding
  • # of employees involved in researchabout 100
  • # of investigators20
  • Number of studies last year30
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday
  • Extended office hoursYes
  • Overnight facilitiesYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL, Other
  • REGULATORY INFORMATION 
  • Contact for regulatory documentsMarta Zakrzewska
  • Regulatory phone number+48225725925
  • # of days to turn around regulatory documents14
  • Type of IRB used by this siteCentral, Local
  • How often does your local IRB meet?Every other week
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • FINANCIAL INFORMATION 
  • # days to turn around budget and contract14

Contacts

  • Teresa Brodniewicz

    President and Scientific & Business Development Director
    MTZ Clinical Research Sp. z o.o.
    Warsaw, Mazowieckie


  • Agata Sosnowska

    Clinical Operation Director
    MTZ Clinical Research Sp. z o.o.
    Warsaw, Mazowieckie